NCT07533344 2026-04-16
PSMA-MRI BX
Fatih Sultan Mehmet Training and Research Hospital
Completed
Clinical Trials
2,942 trialsNCT03935282 2026-04-15
AH-HA
Wake Forest University Health Sciences
Phase NA Completed
NCT01902680 2026-04-14
CURIEFOCALE
Institut Claudius Regaud
Phase 2 Completed
NCT01982786 2026-04-13
Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer
Canadian Cancer Trials Group
Phase NA Completed
NCT02225704 2026-04-13
Radium-223 in Combination With Enzalutamide
Cancer Trials Ireland
Phase 2 Completed
NCT02772588 2026-04-13
AASUR in High Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04081779 2026-04-08
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Fred Hutchinson Cancer Center
Phase NA Completed
NCT04037254 2026-04-06
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
NRG Oncology
Phase 1/2 Completed
NCT04533958 2026-04-06
HypProMet
Saint-Gregoire Private Hospital Center
Phase NA Completed
NCT04582656 2026-04-06
VIOLETTE
Koelis
Phase NA Completed
NCT03660085 2026-04-03
PC-PEP
Nova Scotia Health Authority
Phase NA Completed
NCT05553327 2026-04-01
Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.
Hospital Clinic of Barcelona
Phase NA Completed
NCT03496805 2026-03-31
Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy
Wake Forest University Health Sciences
Phase 2 Completed
NCT03674814 2026-03-31
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer
University of Chicago
Phase 1 Completed
NCT05231915 2026-03-31
HOXB13_Mart
University Hospital Center of Martinique
Phase NA Completed
NCT04705038 2026-03-27
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments
University of Chicago
Phase NA Completed
NCT06435546 2026-03-27
AdOTAC
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT07074405 2026-03-27
AccAI
Centre Hospitalier Universitaire de Liege
Phase NA Completed
NCT04461509 2026-03-25
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
Phase 2 Completed
NCT07489729 2026-03-24
Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer
Tanta University
Phase NA Completed
NCT07491406 2026-03-24
PRS-AS
IRCCS San Raffaele
Completed
NCT07485257 2026-03-20
MP-PET-MRI
IRCCS San Raffaele
Completed
NCT06136598 2026-03-19
MK-5684-001
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT07477756 2026-03-19
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
Novartis
Completed
NCT07428642 2026-03-18
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
Completed
NCT01596816 2026-03-13
CKNO-PRO
Centre Oscar Lambret
Phase 2 Completed
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT07464964 2026-03-11
MUSIC-PRT
Dokuz Eylul University
Phase NA Completed
NCT05012813 2026-03-09
Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT05162846 2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT00160979 2026-03-06
Transrectal Tumour Oxygen - US Army
University Health Network, Toronto
Phase 2 Completed
NCT00936390 2026-03-06
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT01546987 2026-03-06
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT01567800 2026-03-06
Prostate Hypoxia FAZA
University Health Network, Toronto
Phase NA Completed
NCT05764005 2026-03-06
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT06184867 2026-03-06
CATALYST
Rutgers, The State University of New Jersey
Phase NA Completed
NCT00063882 2026-03-05
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT05008900 2026-03-05
TOPP
University Health Network, Toronto
Phase 2 Completed
NCT05999968 2026-03-05
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Eli Lilly and Company
Phase 1 Completed
NCT07448545 2026-03-05
Turkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
Completed
NCT06472856 2026-03-04
VASA Pro
University College Cork
Phase NA Completed
NCT07450157 2026-03-04
A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617
Novartis
Completed
NCT05700903 2026-03-02
ARCH
University of Colorado, Denver
Phase 4 Completed
NCT04443062 2026-02-27
Bullseye
Radboud University Medical Center
Phase 2 Completed
NCT04736199 2026-02-27
ARANOTE
Bayer
Phase 3 Completed
NCT03159676 2026-02-25
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer
Mayo Clinic
Completed
NCT01171898 2026-02-24
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)
Aragon Pharmaceuticals, Inc.
Phase 1/2 Completed
NCT01314118 2026-02-24
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Janssen Biotech, Inc.
Phase 2 Completed
NCT03568188 2026-02-24
FOCALE
Hospices Civils de Lyon
Phase 2 Completed
NCT03388619 2026-02-23
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
National Institutes of Health Clinical Center (CC)
Phase 1 Completed